Inhibrx Biosciences

Filed a patent for "ige binding polypeptides and uses thereof" on Thu, July 13, 2023

Filed a patent for "ige binding polypeptides and uses thereof" on Mon, December 4, 2023

Filed a patent for "nkp46-binding polypeptides and uses thereof" on Thu, February 22, 2024

Filed a patent for "ox40-binding polypeptides and uses thereof" on Thu, December 12, 2024

Filed a patent for "multivalent and multispecific dr5-binding fusion proteins" on Thu, November 14, 2024

Filed a patent for "pd-1 single domain antibodies and therapeutic compositions thereof" on Thu, September 26, 2024

Filed a patent for "nkp46-targeted modified il-2 polypeptides and uses thereof" on Thu, February 22, 2024

Filed a patent for "cd123-binding polypeptides and uses thereof" on Thu, March 2, 2023

Filed a patent for "ox40-binding polypeptides and uses thereof" on Thu, April 27, 2023

Filed a patent for "gamma delta t-cell-binding polypeptides and uses thereof" on Thu, October 20, 2022

Filed a patent for "gamma delta t-cell-targeted modified il-2 polypeptides and uses thereof" on Thu, October 20, 2022

Filed a patent for "canine pd-1-binding polypeptides and uses thereof" on Thu, October 19, 2023

Filed a patent for "cd33-binding polypeptides and uses thereof" on Thu, October 5, 2023

Filed a patent for "multivalent and multispecific 41bb-binding proteins" on Thu, December 28, 2023

Filed a patent for "polypeptides comprising modified il-2 polypeptides and uses thereof" on Thu, July 27, 2023

Filed a patent for "fcrn-binding polypeptides and uses thereof" on Mon, January 9, 2023

Filed a patent for "effective dosage of recombinant serpin-fc fusion protein for use in a method of treating aat deficiency in a subject" on Tue, March 28, 2023

Filed a patent for "dr5 agonist and iap antagonist combination therapy" on Wed, April 5, 2023

Filed a patent for "effective dosage of recombinant serpin-fc fusion protein for use in a method of treating aat deficiency in a subject" on Thu, November 16, 2023

Filed a patent for "multispecific polypeptide constructs having constrained cd3 binding and related methods and uses" on Thu, September 21, 2023

Filed a patent for "siglec-8 binding proteins and uses thereof" on Thu, December 21, 2023

Filed a patent for "non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof" on Thu, May 23, 2024

Filed a patent for "multispecific polypeptide constructs having constrained cd3 binding and methods of using the same" on Thu, March 28, 2024

Filed a patent for "dr5 agonist and plk1 inhibitor combination therapy" on Fri, April 8, 2022

Filed a patent for "siglec-8 binding polypeptides and uses thereof" on Fri, April 22, 2022